Biotech

All Articles

Roivant unveils brand new 'vant' to evolve Bayer high blood pressure med

.Matt Gline is back along with a brand new 'vant' firm, after the Roivant Sciences chief executive o...

Viridian eye health condition period 3 smash hits, evolving push to rivalrous Amgen

.Viridian Therapeutics' phase 3 thyroid eye health condition (TED) scientific trial has reached its ...

Bain introduces $3B fund for life scientific research companies

.Along with a solid track record for recognizing diamonds in the rough, Bain Funds Daily Life Scienc...

Genentech's cancer cells restructure brought in 'for scientific causes'

.The recent decision to merge Genentech's 2 cancer teams was actually produced "scientific causes," ...

Tern oral GLP-1 shows 5% weight management at 1 month at best dosage

.Terns Pharmaceuticals' choice to lose its own liver illness passions may yet pay off, after the bio...

Merck, Daiichi regular very early results in small cell bronchi cancer cells with updated ADC data

.Merck &amp Co.'s long-running effort to land a punch on tiny cell lung cancer (SCLC) has scored a t...

Boehringer, Bayer development bronchi cancer medicines toward Astra struggle

.Some patients with non-small tissue lung cancer (NSCLC) have anomalies in a gene named human skin g...

MBX goes for $136M IPO to take rival to Ascendis right into period 3

.MBX has actually fleshed out programs to absorb over $136 thousand from its own IPO as the biotech ...

Relay bosom cancer cells data tee up clash with AstraZeneca's Truqap

.Relay Rehabs has actually hammered its own survival goal in a first-in-human breast cancer research...

AZ lays out AI-enabled TROP2 biomarker technique for Daiichi ADC

.AstraZeneca has made use of artificial intelligence to design an unique biomarker for its own Daiic...